p.boateng

TL2 · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 11 December 2024 · last posted 18h

96 posts, newest first. Showing up to 150.

About the HPLC & UHPLC category Replied, post #5 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Peer-to-peer review: what actually happens on the call Replied, post #3 · Access › Insurance & coverage · 27 Jul 2026 · 1 like Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #37 · Practice › Interactions · 17 Jul 2026 · 17 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Delayed gastric emptying and oral, because it is the sort of…
Primary endpoint hierarchies and why order matters — one year on Replied, post #49 · Evidence › Trials · 17 Jul 2026 · 2 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Transit times by route, from a logged dataset Replied, post #11 · Sourcing › Logistics · 15 Jul 2026 · 0 likes The most useful reply I ever got about transit times was a request to state my units. It sounds like pedantry and it has saved me twice.
Common supplements people ask about, assessed one at a time Replied, post #45 · Practice › Interactions · 14 Jul 2026 · 7 likes Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.
Follow-up: How compounding permissions changed when supply normalised Replied, post #19 · Sourcing › Regulatory · 14 Jul 2026 · 18 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. On reflection I would soften that…
Pages past their review date, listed — does this still hold? Replied, post #39 · Meta › Wiki maintenance · 5 Jul 2026 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Cross-referencing: if two pages should reference each other but do not, suggesting…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #45 · Clinical › Comorbidities · 24 Jun 2026 · 6 likes Where the PCOS and metabolic overlap discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the…
Pooling trials with different estimands Replied, post #39 · Evidence › Meta-analyses · 21 Jun 2026 · 13 likes Post #38 and I disagree about the size of the effect, not about the direction. Second-hand on pooling trials with different estimands, so weight it accordingly —…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #45 · Analytics › HPLC & UHPLC · 18 Jun 2026 · 0 likes Column temperature affects retention and selectivity and is omitted from most certificates. Two runs at twenty-five and forty degrees are not the same method.
Comparing documentation quality across the directory, tabulated Replied, post #6 · Sourcing › Vendor reports · 16 Jun 2026 · 25 likes This follows post #3 rather than contradicting it. Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one.…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #29 · Evidence › Journal club · 11 Jun 2026 · 24 likes I keep a log for SURMOUNT-OSA specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
Alcohol: what is documented and what is folklore Replied, post #49 · Practice › Interactions · 9 Jun 2026 · 8 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
I joined for one answer and stayed for a year — what changed my mind Replied, post #13 · Start Here › Welcome · 9 Jun 2026 · 4 likes This is the answer, and the reason it is the answer is the more useful part.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #74 · Practice › Storage & stability · 2 Jun 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. A weak preference rather than a position.
Revisiting: Theoretical plates: useful number or ritual? Replied, post #10 · Analytics › HPLC & UHPLC · 30 May 2026 · 7 likes Post #9 put the caveat in the right place and I want to underline it. Method validation is the demonstration that a method can separate the compound from its…
Revisiting: Body image changing more slowly than the body Replied, post #5 · Wellbeing › Mental health · 20 May 2026 · 16 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
Reading a trial's population section before its results Replied, post #35 · Evidence › Trials · 19 May 2026 · 16 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #31 · Practice › Storage & stability · 17 May 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. That is what I would do. It may not be…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #47 · Practice › Reconstitution · 15 May 2026 · 10 likes Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #13 · Start Here › Welcome · 9 May 2026 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #38 · Outcomes › Progress reports · 29 Apr 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Journal club: is percentage weight change the right endpoint? Replied, post #99 · Evidence › Journal club · 24 Apr 2026 · 5 likes Confirming post #98 from a second method, which matters more than confirming it from a second person. The most common failure mode is spending fifty minutes on the…
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #11 · Compounds › Oral incretins · 23 Apr 2026 · 18 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
Does a peptide degrade silently, with no visual change? Replied, post #12 · Practice › Storage & stability · 18 Apr 2026 · 13 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
List price versus negotiated price versus what you pay Replied, post #48 · Access › Pricing · 12 Apr 2026 · 11 likes Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that look identical frequently are not. Worth reading the earlier…
Choosing which test to pay for, given a fixed budget Replied, post #51 · Sourcing › Independent verification · 2 Apr 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Grapefruit: why this class is not the class that cares Replied, post #63 · Practice › Interactions · 21 Mar 2026 · 0 likes Source for the grapefruit figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
Cost per delivered dose, which is the number that matters Replied, post #59 · Access › Pricing · 21 Mar 2026 · 8 likes Nothing here is financial advice and none of it is a route to a transaction.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #66 · Compounds › Repair & healing peptides · 14 Mar 2026 · 7 likes The absence of human trials means there is no established dose, no established interval and no established duration. Protocols circulating in this space are convention…
Forced degradation studies: designing one that is informative Replied, post #16 · Analytics › Method validation · 7 Mar 2026 · 30 likes Appreciated. The plain phrasing does more work here than a longer post would.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #20 · Research Methods › N-of-1 designs · 27 Feb 2026 · 20 likes A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #33 · Research Methods › N-of-1 designs · 18 Feb 2026 · 1 like Duration should be set by how long an effect would take to appear rather than by patience. Stopping early is the commonest reason a personal experiment answers nothing.…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #12 · Compounds › Tirzepatide · 10 Feb 2026 · 5 likes One caution on 2.5 mg starting dose: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #21 · Outcomes › Body composition · 1 Feb 2026 · 12 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #26 · Data & Tools › Calculators · 19 Jan 2026 · 2 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
Aggregates and why a purity assay may miss them entirely Replied, post #41 · Analytics › Impurities & related substances · 31 Dec 2025 · 7 likes Two claims get bundled together under aggregates and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
Filter needles: when they help and what they cost you Replied, post #8 · Devices › Syringes & needles · 20 Dec 2025 · 16 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #20 · Sourcing › Red flags · 19 Dec 2025 · 0 likes What I would check first on supplier is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
What I would record differently if I started again — the long version Replied, post #20 · Outcomes › Progress reports · 17 Dec 2025 · 31 likes I read post #16 twice before replying, because I had assumed the opposite. Self-reported intake is optimistic in a consistent direction, and saying so in your own…
Amylin receptor signalling and satiety — what changed since Replied, post #5 · Pharmacology › Receptor biology · 16 Dec 2025 · 19 likes Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
Waist circumference technique and its repeatability Replied, post #22 · Outcomes › Progress reports · 1 Dec 2025 · 2 likes Taking post #19 at face value and following it one step further. Having read the whole waist circumference technique thread before replying: the question in the first…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #32 · Sourcing › Regulatory · 14 Nov 2025 · 2 likes Compound being unapproved has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
A parcel that arrived warm: a decision process, not a verdict Replied, post #120 · Practice › Storage & stability · 4 Nov 2025 · 31 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. If anyone has run this properly I would…
EU-wide position versus national implementation — what changed since Replied, post #4 · Regional › European Union · 6 Oct 2025 · 5 likes Before the thread moves on from eu-wide position versus national implementation — what is the sample size behind the claim? I am not being difficult; I have seen the…
The headache that turns out to be dehydration Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 26 Sep 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #128 · Evidence › Study critique · 16 Sep 2025 · 6 likes I read post #124 twice before replying, because I had assumed the opposite. Agreed on Reverse causation, with one qualification that I think matters. The reasoning…
Documentation that appears only after payment Replied, post #17 · Sourcing › Red flags · 3 Sep 2025 · 13 likes Small methodological point on documentation: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Follow-up: Why appetite effects are mostly central Replied, post #31 · Pharmacology › Receptor biology · 2 Sep 2025 · 12 likes Understood. Thank you for being specific about the limits of it.
Guidelines revision: what changed and why — one year on Replied, post #12 · Meta › Announcements · 1 Sep 2025 · 0 likes Where I would push back on the Guidelines revision consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #53 · Practice › Dosing & titration · 29 Aug 2025 · 4 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #81 · Evidence › Journal club · 21 Aug 2025 · 16 likes This follows post #80 rather than contradicting it. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that…
Are there stupid questions here? A staff answer, at length Replied, post #34 · Start Here › Welcome · 2 Aug 2025 · 11 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
Second pass at: Sleep tracking data and its considerable limitations Replied, post #3 · Wellbeing › Sleep · 1 Aug 2025 · 0 likes Sleep quality changes reported here have several plausible contributors, and separating drug effects from weight change, from schedule change, and from anxiety is…
How to research a compound with no human data without deceiving yourself Replied, post #40 · Compounds › Other compounds · 1 Aug 2025 · 0 likes Narrowing post #37, because the general version has more than one answer. Research a compound sits at the boundary between what this community can usefully discuss and…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #29 · Compounds › Secretagogues & GH axis · 27 Jul 2025 · 24 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #83 · Compounds › Semaglutide · 23 Jul 2025 · 6 likes Semaglutide half-life is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #57 · Sourcing › Regulatory · 22 Jul 2025 · 2 likes The failure mode on compound being unapproved is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #84 · Evidence › Trials · 22 Jul 2025 · 0 likes One more thing on Comparators chosen for regulatory reasons that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #67 · Compounds › Oral incretins · 20 Jul 2025 · 31 likes Post #64 is right about the mechanism and I think understates the practical bit. Why an oral formulation is a formulation achievement: the molecule is the same but the…
What this community means by "a source", in practical terms Replied, post #40 · Start Here › Welcome · 19 Jul 2025 · 1 like The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #13 · Compounds › Oral incretins · 29 Jun 2025 · 21 likes Thank you for taking the time. That was more work than a reply usually is.
Needle changes between doses on a reusable pen Replied, post #16 · Devices › Pens & autoinjectors · 23 Jun 2025 · 21 likes A pen taken straight from the refrigerator is uncomfortable to inject for the same reason a cold syringe is. Room temperature for a short while first is the standard…
Why plausible mechanism is not evidence of effect Replied, post #16 · Compounds › Repair & healing peptides · 17 Jun 2025 · 4 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
Half-life, steady state, and accumulation worked through Replied, post #67 · Pharmacology › Pharmacokinetics · 5 Jun 2025 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #7 · Access › Insurance & coverage · 4 Jun 2025 · 0 likes Source for the Reading a denial letter figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #17 · Compounds › Repair & healing peptides · 18 May 2025 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
A well-designed study with a badly written abstract Replied, post #88 · Evidence › Study critique · 17 May 2025 · 0 likes Coming back to post #86, because the follow-up matters more than the original answer. The failure mode on well-designed study is boring rather than dramatic. It is…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #26 · Evidence › Journal club · 18 Apr 2025 · 0 likes Having read the whole STEP 1 thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
A supplier that answers analytical questions with restated claims Replied, post #55 · Sourcing › Red flags · 11 Apr 2025 · 1 like Post #52 describes the usual case. This is about the unusual one. A supplier changing batch nomenclature is not a warning sign, and it does make historical comparison…
Carryover and the ghost peak from last week's standard Started this topic · Analytics › HPLC & UHPLC · 30 Mar 2025 · 21 likes On the subject in the title: Carryover and the ghost peak from last week's standard Working notes rather than a conclusion. What changes if the standard account of…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 4 likes Adding the measurement that the opening post says would settle it. The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #19 · Sourcing › Vendor reports · 15 Mar 2025 · 7 likes Narrowing post #16, because the general version has more than one answer. The cost of a submission is worth stating. It is the main reason people do not do this and…
Validating a method you did not develop — does this still hold? Replied, post #61 · Analytics › Method validation · 1 Mar 2025 · 3 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
Follow-up: Open-label extensions: what survives and what does not Replied, post #3 · Evidence › Trials · 27 Feb 2025 · 26 likes The opening post and I disagree about the size of the effect, not about the direction. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #12 · Compounds › Semaglutide · 15 Feb 2025 · 19 likes Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #60 · Sourcing › Regulatory · 9 Jan 2025 · 13 likes The number people quote for Research-use-only labelling is a central estimate presented without its interval, and the interval is wide enough that the estimate is…
Converting between mg/mL and units per dose, both directions Replied, post #130 · Practice › Reconstitution · 14 Dec 2024 · 2 likes Post #128 answers the question as asked. The question underneath it is different. Preservative effectiveness is tested against a defined microbial challenge under…
Two sessions a week versus four: what the evidence supports Replied, post #19 · Nutrition & Training › Resistance training · 30 Nov 2024 · 24 likes Recording sessions is what makes progression visible. Without a log, load creep and load decline both go unnoticed. That is my reading. Someone else read the same page…
[2026 update] New subcategory: rationale and scope Replied, post #31 · Meta › Announcements · 29 Nov 2024 · 28 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. Thank you for announcing it in advance rather than after. The number of places that…
Washout with a one-week half-life: the arithmetic Replied, post #3 · Research Methods › N-of-1 designs · 21 Nov 2024 · 5 likes A washout period between conditions is what stops one bleeding into the next, and its length should be set by the half-life rather than by convenience.
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #27 · Practice › Interactions · 16 Nov 2024 · 20 likes Taking post #26 at face value and following it one step further. Two questions I would want answered before drawing anything from the Grapefruit data above: how were…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #53 · Clinical › Prescriber conversations · 12 Nov 2024 · 6 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. That is the version I would…
Revisiting: Moderation log format change Replied, post #13 · Meta › Announcements · 1 Nov 2024 · 30 likes Taking post #10 at face value and following it one step further. The rare case here is the one that costs somebody a week, though, and the common case costs everyone…
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #4 · Compounds › Oral incretins · 4 Oct 2024 · 33 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #66 · Clinical › Bloodwork · 29 Sep 2024 · 13 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #47 · Compounds › Retatrutide · 19 Sep 2024 · 0 likes Building on post #44 rather than restating it. Glycaemic effects improved rather than worsened in the diabetes work despite the glucagon component, which is the…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #40 · Sourcing › Independent verification · 6 Sep 2024 · 17 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
Revisiting: Five questions in one post gets you one answer — how to split them Replied, post #2 · Start Here › How to Ask · 31 Aug 2024 · 28 likes Picking up the opening post: that is the part I would want checked first. Timeline questions need the timeline. Dates, in order, with what happened on each. "A while…
A rising related-substance total over six months: degradation or method drift? Started this topic · Analytics › Impurities & related substances · 21 Aug 2024 · 3 likes Asking directly, because I could not find a straight answer: A rising related-substance total over six months: degradation or method drift? Rising related-substance — I…
How to ask for a dose change without antagonising anyone Replied, post #13 · Clinical › Prescriber conversations · 10 Aug 2024 · 4 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Promotion criteria, and the one that stops most nominations Replied, post #33 · Documentation › Doc review · 7 Aug 2024 · 22 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #69 · Compounds › Retatrutide · 21 Jul 2024 · 4 likes Noted, and I have changed what I was going to do on the strength of it.
Assessing a warm arrival: the decision process — one year on Replied, post #115 · Sourcing › Logistics · 1 Jun 2024 · 14 likes Delivery to an address where somebody is present is worth more for cold-chain material than any packing decision available to the supplier.
Tracking a preprint to publication: a worked example — the long version Started this topic · Evidence › Preprints · 13 May 2024 · 0 likes Posting this under the heading it deserves: Tracking a preprint to publication: a worked example — the long version Everything below is what sits behind that. A…